Question 1

Does RA Capital Management own KNTE stock?

Accepted Answer

No. RA Capital Management exited its KNTE (Kinnate Biopharma) position in Q2 2023. Its Q1 2023 13F listed 4,264,144 shares worth $26.7M.

Question 2

How many shares of KNTE does RA Capital Management own?

Accepted Answer

None since Q2 2023, when RA Capital Management exited the position. Its Q1 2023 13F listed 4,264,144 shares worth $26.7M.

Question 3

What is RA Capital Management's KNTE position worth?

Accepted Answer

RA Capital Management's KNTE position was worth $26.7M in its Q1 2023 13F, before the exit in Q2 2023.

Question 4

Is RA Capital Management buying or selling KNTE?

Accepted Answer

In Q2 2023, RA Capital Management exited its entire KNTE position.

Question 5

When did RA Capital Management first buy KNTE?

Accepted Answer

RA Capital Management already held KNTE in its Q4 2020 13F, the earliest on record, and listed it in 10 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2023-Q2 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2023-Q1	Unchanged	4.3M	0.0%	$26.7M	0.6%	—	0
2022-Q4	Unchanged	4.3M	0.0%	$26M	0.5%	—	0
2022-Q3	Unchanged	4.3M	0.0%	$51M	1.1%	—	0
2022-Q2	Unchanged	4.3M	0.0%	$53.8M	1.4%	—	0
2022-Q1	Increased	4.3M	+18.7%	$48M	1.0%	—	54
2021-Q4	Unchanged	3.6M	0.0%	$63.7M	1.1%	—	0
2021-Q3	Unchanged	3.6M	0.0%	$82.7M	1.1%	—	0
2021-Q2	Unchanged	3.6M	0.0%	$83.6M	1.3%	—	0
2021-Q1	Unchanged	3.6M	0.0%	$112M	1.7%	—	0
2020-Q4	New	3.6M	-	$142.9M	2.0%	—	69

KNTE11 quarters

KNTE
11 quarters